115 results on '"Del, Giudice"'
Search Results
2. Is there a role for Bacillus Calmette-Güerin in very high-risk non-muscle invasive bladder carcinoma? Multicenter analysis of oncological outcomes and risk dynamics
3. The optimal way to determine kidney function for cisplatin-based neoadjuvant chemotherapy in muscle-invasive bladder cancer: A European Association of Urology young academic urologists urothelial cancer working group multi-institutional study
4. Natural history of cN+ bladder cancer treated with radical cystectomy with or without perioperative treatment
5. New minimally invasive techniques versus gold standard approach for middle volume (30-80 ml) prostates: A multicentre prospective randomized study
6. The optimal number of induction chemotherapy cycles in cN+ bladder cancer
7. Risk of upper urinary tract dissemination in cT3 bladder cancer patients treated with Double J stent versus nephrostomy tube prior to radical cystectomy
8. Diagnostic accuracy and inter-reader agreement of nac-VIRADS scoring system: A prospective validation study
9. Multicentre study on premature ejaculation treatment with pelvic floor muscle rehabilitation: Analysis of 5 years results
10. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non–muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection
11. Trends and incidence of reported events associated with staplers: An analysis of the food and drug administration’s manufacturer and user facility device experience database
12. Do serum inflammatory indexes predict prostatic inflammation
13. Immune responses against SARS-CoV-2 wildtype in unvaccinated patients with high-risk NMIBC undergoing intravesical BCG therapy
14. 5-Alpha Reductase inhibitors (5-ARi) with or without alpha-blockers for benign prostatic hyperplasia do not lower the risk of incident bladder cancer: An analysis of US insurance claims data
15. Survival analysis of patients with T1LG bladder cancer treated with BCG immunotherapy
16. The effect of semen parameters on pregnancy rate from assisted reproduction technologies: Systematic review and meta-analysis
17. Compared Efficacy of Adjuvant Intravesical BCG TICE vs. RIVM for High-risk Non-muscle Invasive Bladder Cancer: A Multicenter Propensity Score Matched Analysis
18. Survival analysis of patients with T1LG bladder cancer treated with BCG immunotherapy
19. The role of extended versus standard lymphadenectomy lymph node dissection in clinically lymph node-positive bladder cancer
20. Progression-free survival as surrogate endpoint in high-risk non-muscle invasive bladder cancer studies: Results from a machine learning-based analysis of a large multi-institutional database
21. Carboplatin induction chemotherapy in clinically lymph node-positive bladder cancer
22. A novel pathway to detect Muscle-Invasive Bladder Cancer (MIBC) combining clinical features and preoperative VI-RADS scoring criteria: Results from a prospective multicenter validation analysis
23. Trends and incidence of reported events associated with ureteral stents: An analysis of the food and drug administration’s manufacturer and user facility device experience database
24. Immune responses against SARS-CoV-2 wildtype in unvaccinated patients with high-risk NMIBC undergoing intravesical BCG therapy
25. Trends and incidence of reported events associated with staplers: An analysis of the food and drug administration’s manufacturer and user facility device experience database
26. Diagnostic performance of Node-RADS by preoperative CT or MRI scans for prediction of pathological Nodal (pN) status from Muscle-Invasive Bladder Cancers (MIBCs) undergoing Radical Cystectomy (RC) with extended Pelvic Lymph-node Dissection (ePLND)
27. Clinical validation of the EAU2021 intermediate risk NMIBC definition and implications for adjuvant treatment: A multicenter YAU Urothelial Collaboration
28. 5-Alpha Reductase inhibitors (5-ARi) with or without alpha-blockers for benign prostatic hyperplasia do not lower the risk of incident bladder cancer: An analysis of US insurance claims data
29. Do serum inflammatory indexes predict prostatic inflammation
30. Major adverse cardiovascular events (MACE) related to phosphodiesterase 5 inhibitors (PDE5i): Analysis of real-life data from Eudra-Vigilance (EV) database
31. Is there any difference between cognitive and fusion biopsies when performed by residents?
32. Long term follow-up outcomes of pelvic floor rehabilitation in subjects suffering from lifelong premature ejaculation: Retrospective multicentre study
33. Contemporary trends in the surgical management of stress urinary incontinence after radical prostatectomy in the united states: Insurance claim data on socio-demographic/ surgical predictors and differential average costs analysis
34. Time for Double-J (DJ) indwelling ureteral stent removal following primary or salvage pyeloplasty in US adult patients is affected by demographic and perioperative factors: Results from a large population-based cohort analysis
35. A0809 - The effect of semen parameters on pregnancy rate from assisted reproduction technologies: Systematic review and meta-analysis
36. A0163 - Compared Efficacy of Adjuvant Intravesical BCG TICE vs. RIVM for High-risk Non-muscle Invasive Bladder Cancer: A Multicenter Propensity Score Matched Analysis
37. Contemporary trends of systemic neoadjuvant and adjuvant intravesical chemotherapy for upper tract urothelial carcinomas undergoing minimally invasive or open radical nephroureterectomy: US-claims analysis on perioperative and health care costs outcomes
38. The influence of operative time and blood loss on surgical margins and functional outcomes at laparoscopic versus robotic-assisted radical prostatectomy: A prospective multicenter study
39. Safety and feasibility of outpatient surgery in benign prostatic hyperplasia: A systematic review and meta-analysis
40. Modeling the contribution of preoperative VI-RADS score to predict final pathologic lymph-node involvement in patients with MIBC undergone radical cystectomy
41. The effect of semen parameters on pregnancy rate from assisted reproduction technologies: Systematic review and meta-analysis
42. A1102 - Multicentre study on premature ejaculation treatment with pelvic floor muscle rehabilitation: Analysis of 5 years results
43. A0896 - The optimal number of induction chemotherapy cycles in cN+ bladder cancer
44. A0686 - New minimally invasive techniques versus gold standard approach for middle volume (30-80 ml) prostates: A multicentre prospective randomized study
45. A0485 - Diagnostic accuracy and inter-reader agreement of nac-VIRADS scoring system: A prospective validation study
46. A0477 - Risk of upper urinary tract dissemination in cT3 bladder cancer patients treated with Double J stent versus nephrostomy tube prior to radical cystectomy
47. A0143 - The optimal way to determine kidney function for cisplatin-based neoadjuvant chemotherapy in muscle-invasive bladder cancer: A European Association of Urology young academic urologists urothelial cancer working group multi-institutional study
48. P277 - Is there a role for Bacillus Calmette-Güerin in very high-risk non-muscle invasive bladder carcinoma? Multicenter analysis of oncological outcomes and risk dynamics
49. P227 - The impact of venous thromboembolism on bladder cancer patients undergoing open or minimally-invasive radical cystectomy in the United States: Perioperative outcomes and health-care costs from insurance claims data
50. P215 - Natural history of cN+ bladder cancer treated with radical cystectomy with or without perioperative treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.